Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

Cardiovascular system

Cardiovascular system

Cardiovascular system

Blood and blood forming organs

Nervous system

Dermatologicals

Sensory organs

Ophthalmology

Respiratory system

Antineoplastic and immunomodulating agents

Azelnidipine

Azilsartan (Base)

Azilsartan Medoxomil Potassium

Betrixaban

Brivaracetam

Crisaborole

Nervous system

Nervous system

Deutetrabenazine

Li�tegrast

Netarsudil

Tezacaftor

Valbenazine

Tofacitinib (Base)

APIs - Under Development Therapeutic Area (Broader Terms)

June 2018

Regulatory Filings

A robust pipeline of 5 novel

molecules and 3 specialty

products in various stages of

clinical development, primarily

focused in the areas of

Oncology, Respiratory and

Dermatology

Drug Discovery, Formulations

and API

Front ends in key

markets of US, Europe,

India, Asia, Africa,

Latam, Russia & CIS

5 Drug Discovery and R&D

centers in Switzerland and India

16 manufacturing

facilities in US,

Argentina, Czech

and India

More than 13,000 employees

from 60 nationalities

Glenmark among Top 75 Biotech firms of the world.*

C

B

D

E

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

Alimentary tract and metabolismEsomeprazole Mg (Trihydrate)

Alimentary tract and metabolismDapagli�ozin

APIs - Validated Therapeutic Area Regulatory Filings

June 2018

Genito urinary system and sex hormones

Various

Alimentary tract and metabolism

Respiratory system

Nervous system

Cardiovascular system

Cardiovascular system

Dermatologicals

Alimentary tract and metabolism

Darifenacin

Deferasirox

Deoxycholic Acid

Desloratadine

Dimethyl Fumarate

Dipyridamole

Dronedarone

E�naconazole

Esomeprazole Mg (Dihydrate)

Blood and blood forming organs

Antiinfectives for systemic use

Dabigatran

Daclatasvir Dihydrochloride (Navel)

DermatologicalsAzelaic Acid

Cardiovascular system

Respiratory System

Cardiovascular system

Nervous system

Dermatologicals

Alimentary tract and metabolism

Cardiovascular system

Blood and blood forming organs

Antiinfectives for systemic use

Bisoprolol Fumarate

Bilastine

Bosentan

Bupropion HCl

Butena�ne HCl

Canagli�ozin

Cilazapril

Cilostazol

Colistimethate Na

A

Cardiovascular system

Blood and blood forming organs

Antineoplastic and immunomodulating agents

Alimentary tract and metabolism

Respiratory system

Antipsychotics

Antiparasitic products, insecticides and repellents

Amiodarone

Apixaban

Apremilast

Aprepitant

Arformoterol

Atomoxetine

Atovaquone

Adapalene

Alogliptin

Dermatologicals

Alimentary tract and metabolism

O

N

F

G

I

L

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

APIs - Validated Therapeutic Area Regulatory Filings

June 2018

Sensory organs

Cardiovascular system

Olopatadine

Olmesartan

M Nervous system

Genito urinary system and sex hormones

Cardiovascular system

Pain

Nervous System

Respiratory system

Milnacipran

Mirabegron

Moexipril

Naproxen Sodium

Naloxone

Nintedanib

Nervous systemLurasidone

DermatologicalsLuliconazole

Nervous systemLornoxicam

Nervous system

Antineoplastic and immunomodulating agents

Cardiovascular system

Nervous system

Antiinfectives for systemic use

Alimentary tract and metabolism

Nervous system

Antiinfectives for systemic use

Alimentary tract and metabolism

Dermatologicals

Respiratory system

Nervous system

Cardiovascular system

Respiratory system

Alimentary tract and metabolism

Eszopiclone

Etoricoxib

Ezetimibe

Fingolimod

Fluconazole

Fosaprepitant

Frovatriptan

Garenoxacin

Glimepiride

Imiquimod

Ivacaftor

Lacosamide

Lercanidipine

Levocetirizine

Linagliptin

Alimentary tract and metabolismEsomeprazole Sodium

Nervous system

Cardiovascular system

Respiratory system

Lithium Carbonate

Lomitapide

Loratadine

Alimentary tract and metabolismOmeprazole

Genito urinary system and sex hormonesOspemifene

S

R

P

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

APIs - Validated Therapeutic Area Regulatory Filings

June 2018

Cardiovascular system

Genito urinary system and sex hormones

Trandolapril

Trospium

Nervous system

Cardiovascular system

Cardiovascular system

Respiratory system

Blood and blood forming organs

Cardiovascular system

Oxcarbazepine

Perindopril Erbumine

Perindopril Arginine

Pirfenidone

Prasugrel

Pravastatin

Antiparasitic products, insecticides and repellentsProguanil

Alimentary tract and metabolism

Dermatologicals

Saxagliptin

Sertaconazole Nitrate

Cardiovascular system

Nervous system

Nervous system

Nervous system

Blood and blood forming organs

Nervous system

Respiratory system

Nervous system

Cardiovascular system

Nervous system

Ranolazine

Rasagiline Mesylate

Rasagiline Tartarate

Riluzole

Rivaroxaban

Rizatriptan

Ro�umilast

Ropinirole

Rosuvastatin Calcium

Ru�namide

Nervous systemTopiramate

Dermatologicals

Antiinfectives for systemic use

Cardiovascular system

Alimentary tract and metabolism

Nervous system

Blood and blood forming organs

Tavaborole

Terbina�ne HCl

Telmisartan

Teneligliptin

Teri�unomide

Ticagrelor

T Cardiovascular systemTadala�l

Genito urinary system and sex hormonesSolifenacin Succinate

Alimentary tract and metabolismSitagliptin

Antineoplastic and immunomodulating agentsTofacitinib Citrate

Z

V

U

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

APIs - Validated Therapeutic Area Regulatory Filings

June 2018

Alimentary tract and metabolism

Nervous system

Alimentary tract and metabolism

Antiinfectives for systemic use

Nervous system

Nervous system

Nervous system

Ursodiol

Vilazodone

Vildagliptin

Voriconazole

Zolmitriptan

Zolpidem

Zonisamide